HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David S Salomon Selected Research

Ovarian Neoplasms (Ovarian Cancer)

7/2008Cell type dependent endocytic internalization of ErbB2 with an artificial peptide ligand that binds to ErbB2.
11/2002Transforming growth factor alpha, amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David S Salomon Research Topics

Disease

36Neoplasms (Cancer)
10/2023 - 03/2002
11Breast Neoplasms (Breast Cancer)
10/2023 - 01/2004
11Carcinoma (Carcinomatosis)
01/2016 - 11/2002
7Carcinogenesis
04/2016 - 03/2002
4Triple Negative Breast Neoplasms
01/2020 - 05/2015
4Colonic Neoplasms (Colon Cancer)
01/2013 - 09/2006
3Lewis Lung Carcinoma
10/2018 - 01/2012
2Pancreatic Neoplasms (Pancreatic Cancer)
06/2023 - 12/2020
2Neoplasm Metastasis (Metastasis)
01/2020 - 06/2010
2Ovarian Neoplasms (Ovarian Cancer)
07/2008 - 11/2002
2Endometriosis
09/2007 - 04/2005
1Tics (Tic)
04/2016
1Embryonal Carcinoma
01/2016
1Adenocarcinoma
05/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2014
1Lung Neoplasms (Lung Cancer)
01/2014
1Inflammation (Inflammations)
06/2013
1Teratoma (Teratoid Tumor)
01/2013
1Hypoxia (Hypoxemia)
11/2009
1Melanoma (Melanoma, Malignant)
07/2008
1Pain (Aches)
09/2007

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
10/2023 - 01/2004
15Epidermal Growth Factor (EGF)IBA
01/2022 - 03/2002
8Conditioned Culture MediaIBA
10/2023 - 10/2007
6Peptides (Polypeptides)IBA
01/2013 - 11/2002
4Messenger RNA (mRNA)IBA
05/2015 - 10/2004
4LigandsIBA
01/2013 - 01/2006
4Transforming Growth Factor beta (TGF-beta)IBA
09/2008 - 11/2005
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2021 - 03/2002
3Transcription Factors (Transcription Factor)IBA
04/2016 - 11/2004
3Phosphotransferases (Kinase)IBA
01/2013 - 11/2004
3Membrane Proteins (Integral Membrane Proteins)IBA
02/2009 - 02/2008
3beta CateninIBA
09/2008 - 11/2004
2Epithelial Cell Adhesion MoleculeIBA
10/2023 - 06/2023
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2023 - 01/2004
2AntibodiesIBA
12/2020 - 07/2008
2CateninsIBA
04/2016 - 01/2013
2Tyrosine Kinase InhibitorsIBA
07/2014 - 07/2008
2Trastuzumab (Herceptin)FDA Link
01/2014 - 01/2013
2Caveolin 1IBA
01/2013 - 02/2008
2Cadherins (E-Cadherin)IBA
06/2012 - 11/2004
2VimentinIBA
06/2012 - 11/2004
2Glycoproteins (Glycoprotein)IBA
08/2010 - 09/2006
2Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
08/2010 - 09/2006
2ErbB Receptors (EGF Receptor)IBA
07/2008 - 01/2006
2Transforming Growth Factor alpha (TGF-alpha)IBA
10/2004 - 11/2002
1Prolactin Receptors (Prolactin Receptor)IBA
10/2023
1Keratin-8 (Keratin 8)IBA
10/2023
1Progesterone Receptors (Progesterone Receptor)IBA
10/2023
1Chir 99021IBA
06/2023
1AZD 6244IBA
06/2023
1oncofetal antigensIBA
09/2021
1CarcinogensIBA
09/2021
1AntigensIBA
05/2021
1Immune Checkpoint InhibitorsIBA
05/2021
1Tissue Inhibitor of Metalloproteinase-2IBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1sulforaphaneIBA
01/2019
1Aldehyde DehydrogenaseIBA
01/2019
1Docetaxel (Taxotere)FDA Link
01/2016
1Glutathione (Reduced Glutathione)IBA
01/2016
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2016
1MicroRNAs (MicroRNA)IBA
05/2015
1Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2014
1Gefitinib (Iressa)FDA Link
07/2014
1Liposomes (Liposome)IBA
01/2014
1Hormones (Hormone)IBA
06/2013
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
06/2013
1Member 1 Group A Nuclear Receptor Subfamily 6IBA
06/2013
1ApelinIBA
06/2013
1Histone Deacetylase InhibitorsIBA
06/2013
1DNA (Deoxyribonucleic Acid)IBA
06/2013
1SC1 compoundIBA
01/2013
1Phenobarbital (Luminal)FDA Link
01/2013
1Steroid Receptors (Steroid Receptor)IBA
01/2013
1AgarIBA
01/2013
1GTP Phosphohydrolases (GTPases)IBA
01/2013
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2013
1TCF Transcription FactorsIBA
01/2013
1Eosinophil Cationic ProteinIBA
10/2012
1SuspensionsIBA
01/2012
1Blocking AntibodiesIBA
07/2010
1tyrosine receptor (receptor, tyrosine)IBA
06/2010
1Oxygen (Dioxygen)IBA
11/2009
1VaccinesIBA
02/2009
1Transforming Growth Factor beta1 (TGF beta 1)IBA
04/2008
1LuciferasesIBA
04/2008
1Mitogen-Activated Protein KinasesIBA
02/2008
1lysophosphatidic acidIBA
10/2007
1Chemotactic FactorsIBA
10/2007
1von Willebrand FactorIBA
09/2007
1Substance PIBA
09/2007
1GAP-43 Protein (GAP 43 Protein)IBA
09/2007
1Nerve Growth Factor (NGF)IBA
09/2007

Therapy/Procedure

9Therapeutics
06/2023 - 07/2008
2Lasers (Laser)
01/2016 - 05/2015
1Immunotherapy
05/2021
1Intraperitoneal Injections
01/2019
1Injections
05/2013
1Aftercare (After-Treatment)
10/2007